We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Advisers Recommend Approval of BioPartners' Valtropin
EMEA Advisers Recommend Approval of BioPartners' Valtropin
March 7, 2006
A European Medicines Agency (EMEA) advisory committee has recommended that European pharmaceutical regulators approve Swiss biotech firm BioPartners’ generic human growth hormone Valtropin.